Do I still need to take molnupiravir capsules if my symptoms turn negative after three days?

Molnupiravir capsules (Molnupiravir) is a drug used to treat COVID-19. Its standard treatment regimen usually recommends continuous use for 5 days. However, whether it is necessary to continue treatment after three days of taking it needs to be decided based on the patient's specific situation, the doctor's advice and the latest clinical guidelines.

Here are some considerations:

1. Early treatment: The best effects of Monoravir capsules usually occur early after infection. The use of drugs in the early stages of infection is expected to better inhibit viral replication, reduce symptoms, and reduce the risk of hospitalization. Therefore, doctors usually recommend starting treatment within 48 hours of symptom onset and continuing for 5 days.

2. Individual Condition: Patients' condition and severity of symptoms may vary. Some people may experience significant symptom relief and a drop in viral load after three days of treatment, while others may need longer treatment. Doctors usually evaluate the need for continued treatment on a patient-by-case basis.

3. Doctor’s advice: Most importantly, patients should decide whether to continue treatment based on their doctor’s advice. Doctors will develop the most appropriate treatment plan based on the patient's condition, clinical guidelines and the latest scientific evidence.

4. Clinical Guidelines: COVID-19 Treatment options and clinical guidelines may be continuously updated with research progress and new scientific data. Patients and doctors should pay attention to the latest treatment guidelines issued by local health departments and authoritative organizations such as the World Health Organization.

Monolavir capsules are already on the market in China, but are not yet included in medical insurance. Please consult your local hospital pharmacy for specific prices. The cheaper ones abroad are Indian generic drugs, which cost around three to four hundred yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.